Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 6894374, 19 pages
https://doi.org/10.1155/2017/6894374
Clinical Study

T-Cell Subsets in Rheumatoid Arthritis Patients on Long-Term Anti-TNF or IL-6 Receptor Blocker Therapy

1Department of Rheumatology and Immunology, Faculty of Medicine, Albert Szent-Györgyi Health Center, University of Szeged, Szeged, Hungary
2First Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary
3First Department of Pediatrics, Semmelweis University, Budapest, Hungary
4Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary

Correspondence should be addressed to Gergely Toldi; moc.oohay@ylegregidlot

Received 14 February 2017; Revised 22 May 2017; Accepted 19 July 2017; Published 25 October 2017

Academic Editor: Tânia Silvia Fröde

Copyright © 2017 Sonja Dulic et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [7 citations]

The following is the list of published articles that have cited the current article.

  • Sonja Dulic, Zsofia Vasarhelyi, Anna Bajnok, Balazs Szalay, Gergely Toldi, Laszlo Kovacs, and Attila Balog, “The Impact of Anti-TNF Therapy on CD4+ and CD8+ Cell Subsets in Ankylosing Spondylitis,” Pathobiology, 2017. View at Publisher · View at Google Scholar
  • Suping Qin, Dexu Sun, Xiangyang Li, Fanyun Kong, Qian Yu, Hui Hua, Kuiyang Zheng, and Renxian Tang, “GANT61 alleviates arthritic symptoms by targeting fibroblast-like synoviocytes in CIA rats,” Journal of Orthopaedic Science, 2018. View at Publisher · View at Google Scholar
  • Jingyu Chen, Ying Wang, Huaxun Wu, Shangxue Yan, Yan Chang, and Wei Wei, “A Modified Compound From Paeoniflorin, CP-25, Suppressed Immune Responses and Synovium Inflammation in Collagen-Induced Arthritis Mice,” Frontiers in Pharmacology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Jean-Luc Davignon, Benjamin Rauwel, Yannick Degboé, Arnaud Constantin, Jean-Fredéric Boyer, Andrey Kruglov, and Alain Cantagrel, “Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review,” Arthritis Research & Therapy, vol. 20, no. 1, 2018. View at Publisher · View at Google Scholar
  • Giovanni Almanzar, Felix Kienle, Marc Schmalzing, Anna Maas, Hans-Peter Tony, and Martina Prelog, “Tofacitinib modulates the VZV-specific CD4+ T cell immune response in vitro in lymphocytes of patients with rheumatoid arthritis,” Rheumatology, 2019. View at Publisher · View at Google Scholar
  • Silvia Menegatti, Elisabetta Bianchi, and Lars Rogge, “Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses,” Frontiers in Immunology, vol. 10, 2019. View at Publisher · View at Google Scholar
  • Shyi-Jou Chen, Gu-Jiun Lin, Jing-Wun Chen, Kai-Chen Wang, Chiung-Hsi Tien, Chih-Fen Hu, Chia-Ning Chang, Wan-Fu Hsu, Hueng-Chuen Fan, and Huey-Kang Sytwu, “Immunopathogenic Mechanisms and Novel Immune-Modulated Therapies in Rheumatoid Arthritis,” International Journal of Molecular Sciences, vol. 20, no. 6, pp. 1332, 2019. View at Publisher · View at Google Scholar